Detection of Methicillin-Resistant Staphylococcus aureus in Clinical and Subclinical Mastitis in Ruminants and Studying the Effect of Novel Green Synthetized Nanoparticles as One of the Alternative Treatments
Table 7
Infected rats’ whole blood picture following treatment with A. herb Alba TiO2 NPs and antibiotics.
Blood parameters
Group (G1) M. vale ± SD
Group (G2) M. vale ± SD
Group (G31) M. vale ± SD
Group (G4) M. vale ± SD
Hb (g/dL)
14.8 ± 0.034
12.7 ± 0.56
14.6 ± 0.287
14.2 ± 0.87
RBC (106/UL)
8.5 ± 0.933
7.9 ± 0.234
8.1 ± 0.023
8.2 ± 0.023
WBC (103/UL)
10.2 ± 0.533
12 ± 0.25
11.4 ± 0.02
13.30 ± 0.34
Neutrophils (103/cm)
0.87 ± 0.45
0.52 ± 0.65
1.0 ± 0.02
0.72 ± 0.02
Lymphocytes (103/cm)
7.3 ± 0.34
13.00 ± 0.5
11.0 ± 0.03
7.40 ± 0.023
Monocytes (103/cm)
0.33 ± 0.03
0.36 ± 0.01
0.15 ± 0.04
0.10 ± 0.01
Eosinophils (103/cm)
0.00 ± 0.00
0.03 ± 0.00
0.12 ± 0.2
0.01 ± 0.0
Basophils (103/cm)
0.00 ± 0.0
0.00 ± 0.00
0.02 ± 0.01
0.01 ± 0.0
PLT (103/UL)
554 ± 0.06
448 ± 0.93
590 ± 0.345
603 ± 1.56
HCT (%)
46.9 ± 0.34
44.8 ± 0.83
46.3 ± 0.98
46.4 ± 98.0
MCV (fL)
59 ± 0.56
57 ± 0.62
58.3 ± 0.54
58.2 ± 0.0876
MCH (pg)
20.0 ± 0.56
17 ± 0.54
20 ± 0.32
21 ± 0.98
MCHC (g/dL)
32 ± 0.567
29 ± 0.84
30 ± 0.98
31 ± 0.35
RDW-CV (%)
12.40 ± 0.345
10.6 ± 0.93
11.7 ± 0.56
11.8 ± 0.98
MPV (fL)
7 ± 0.123
6.5 ± 0.25
7.07 ± 0.23
6.30 ± 0.65
Mean values of different parameters ± stander division (SD) and all values significant at () Approx. highlysignificant at (). (G1): negative control; (G2): rats were infected with MRSA without treatment (positive control); (G3):rats infected with MRSA and treated with ciprofloxacin; and (G4):rats infected with MRSA and treated A. herb Alba TiO2 NPs.
